Dr Mardi Gomberg
@mardigomberg
Director Pulmonary Hypertension Program
ID:2762552987
06-09-2014 03:23:18
66 Tweets
148 Followers
23 Following
Take homes from Courage and Innovation Symposium session 2.
Nitasha Sarswat: amyloid fibril depleters & CRISPR are on the horizon.
Jeanne DeCara: use steroids early in checkpoint inhibitor myocarditis, rechallenging ICU risky.
Hena Patel MD: most ACEi & spiro ok w lactation in peripartum CM.
Great program put together by Ben Chung MD & Sara Kalantari MD!
Ben took a picture of the 1 HFrEF slide 😂. Appreciated the opportunity to talk about the growing evidence for #SQUAD -therapy for HFpEF
x.com/MarkBelkinMD/s…
Double-dipping on PH learning from the homecoming of Dr Mardi Gomberg as Cardiology Grand Rounds lecturer yesterday and the keynote speaker Courage and Innovation Symposium today!
Asked how he and Yale University would respond to a person at the university who called for the genocide of Jews, Yale President Peter Salovey said:
“What was asked of other university leaders at recent Congressional hearings has raised questions about our policies and practices. Let me…
Excellent discussion on PAH & comorbidities and disease modification CVCT - CardioVascular Clinical Trialists. Thanks to the organizers Faiez ZANNAD Jason Weatherald MD Olivier Sitbon Jean-Luc Vachiery 🫀 Vallerie McLaughlin Dr Mardi Gomberg Yogesh Reddy Mitchell Psotka Steven Kawut The Pulmonary Hypertension Association ATS PC Assembly
CardioNerds Journal Club Additional comment on AEs- some had symptoms of an 'increase in prostacyclin' they didn't need as much- this is a hot topic Anjali Vaidya MD 🫀 Ryan J Tedford MD thoughts?
Dr Mardi Gomberg-Maitland presents phenotypic and enrichment of PAH trials. She emphasizes that “These are not new issues” and highlights what’s new in 2021. #CVCT2021 CVCT - CardioVascular Clinical Trialists Dr Rani Khatib FESC Diego Araiza MD Dr.Rajiv Sankaranarayanan Aaysha Cader Alex Nowbar Alexander Hajduczok, MD 🇺🇦🙏 Anju Bhardwaj MD FACC
Might Bayesian analysis help? Prof Eric Vicaut compares and contrasts Bayesian and Frequentist approaches in improving PAH trial design. #CVCT2021 CVCT - CardioVascular Clinical Trialists Aaysha Cader Carlos G Santos-Gallego, MD Diego Araiza MD Dr Rani Khatib FESC Harriette Van Spall, MD MPH Faiez ZANNAD
Excellent presentation by Dr Steven Kawut on practical issues to consider with PAH trial designs:
1. Background therapy
2. Placebo vs active control
3. Add-on vs Replacement
4. Single drug va strategies comparison. #CVCT2021 Diego Araiza MD Dr Rani Khatib FESC CVCT - CardioVascular Clinical Trialists
Brent NOWICKI (FINA): Siphiwe Baleka DEVE participar nas Olimpiadas 2021 - Sign the Petition! chng.it/PGHfCLFm via Change.org please help an old friend